Down 15% from its peak, are CBA shares fully a buy according to JP Morgan?

Let's find out whether CBA shares are a buy, hold or sell according to the investment bank.

| More on:
Key points
  • After peaking at $192, Commonwealth Bank of Australia (ASX: CBA) shares have declined to $164.88.
  • JP Morgan, while acknowledging CBA's structural advantages, maintains an 'Underweight' rating, indicating potential for further decline before the stock is considered value-priced.
  • CBA’s high valuation ratios and cautious outlook have led to tempered expectations, with both JP Morgan and Macquarie Group setting price targets below the current share price.

For the past couple of years, experts have continued to warn that CBA shares were overvalued. 

Despite such warnings, Commonwealth Bank of Australia (ASX: CBA) continued to rise, peaking at $192 earlier this year. 

Since then, CBA shares have steadily declined in value. 

Friday, they closed at $164.88, which is nearly 15% below their peak. 

ASX investors may be wondering whether CBA shares are finally good value.

Last week, Macquarie Group Ltd (ASX: MQG) upgraded its price target on CBA shares. However, this was a minor increase from $105 to $106, which is still well below the current share price. 

Does JP Morgan Chase & Co (NYSE: JPM) have a higher price target? Let's find out.

A group of market analysts sit and stand around their computers in an open-plan office environment.

Image source: Getty Images

JP Morgan analyses CBA's FY25 result

After reviewing CBA's FY25 result, which caused CBA shares to drop 5.4%, JP Morgan released a new research note on 13 August. 

The investment bank summarised four key takeaways from the result. Firstly, CBA's cash net profit after tax (NPAT) of $10.25 billion was in line with JP Morgan's forecasts; however, management struck a more cautious tone on its outlook. Secondly, the CBA's net interest margin (NIM) is stable, but pressure will continue. Thirdly, JP Morgan noted persistent competition across the balance sheet. Fourthly, while CBA's retail main financial institution (MFI) fell from 35.5% to 33.2%, with other major banks improving, it remains the market leader.

The investment bank also noted that CBA's operating expense growth of 6.1% (or 5.9% excluding inflation) has stepped up meaningfully over the past two years.

However, JP Morgan said the result was in line with its forecast, resulting in immaterial changes to their FY26 and FY27 forecasts. 

Commenting on the share price reaction, JP Morgan said:

It's tempting to think that the severe market reaction (share price -5.4% vs. ASX 200 -0.6%) is overdone. However, context is important; this broke a run of small EPS upgrades this calendar year, and the shares were likely pricing in greater expectations, as valuation was already very stretched before today.

CBA continued to trade on a forward price-to-earnings ratio of 27 and price-to-book ratio of 3.5.  It also has a return on equity of 13.1%. These numbers make it "arguably the most expensive developed market bank in the world", according to JP Morgan. 

In its research note, JP Morgan outlined several positives for the bank. It said CBA has structural advantages over other major banks due to its peer-leading deposit franchise, very strong proprietary retail banking franchise, superior scale, higher MFI score and technology advantage.

JP Morgan more optimistic than Macquarie

Following the result, JP Morgan provided its price target on the CBA shares. 

The investment bank reiterated its 'Underweight' rating and price target of $120. 

While this is above Macquarie's price target of $106, it suggests the stock has significantly further to fall before it is attractively valued.

JPMorgan Chase is an advertising partner of Motley Fool Money. Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended JPMorgan Chase and Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Westpac and CBA shares

A leading expert forecasts growing headwinds for Westpac and CBA shares.

Read more »

Man looking at digital holograms of graphs, charts, and data.
Broker Notes

Expert names 2 ASX tech shares to buy today

A top analyst says these two ASX tech stocks are well-positioned to outperform.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Broker Notes

4 ASX All Ords shares with 40% to 90% upside post-results: experts

These shares have major upside potential, according to the experts.

Read more »

Woman looking at a laptop and thinking.
Broker Notes

4 ASX shares scoring upgrades in the final week of earnings season

Brokers have increased their ratings on Sigma Healthcare, Adairs, Netwealth, and other shares.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Buy, hold, sell: Netwealth, Sigma Healthcare, and Wesfarmers shares

The team at Morgans has given its verdict on these shares.

Read more »

Smiling kid flexing his muscles.
Broker Notes

3 ASX 200 shares to buy post-results: broker

Morgans has reviewed these companies' FY26 reports and given them a buy rating.

Read more »

Small kid giving a thumbs up.
Broker Notes

9 ASX 200 shares with strengthened buy ratings this week

Brokers are positive on Paladin Energy, Coles, WiseTech, Centuria Capital, and other shares.

Read more »

A couple in a supermarket laugh as they discuss which fruits and vegetables to buy
Broker Notes

Buy, hold, sell: Ramsay Health Care, PLS Group, Woolworths shares

Morgans has updated its ratings and 12-month price targets on these 3 ASX 200 shares.

Read more »